Technical Articles

重组人il-15蛋白在 NK 细胞治疗里站在哪一环?三条路线与各自的证据
Where IL-15 Stands in NK Cell Therapy: Three Routes and the Evidence Each Demands
发布时间 2026-11-16
From ex vivo NK expansion to IL-15 superagonist fusions and CAR-NK programs, IL-15 sits at the evidence gate of each route. This article traces the chain.
View details
  • Immunity/Inflamma
  • IL-15
  • NK cell therapy
  • CAR-NK
  • IL-15 superagonist
  • ex vivo expansion
  • UA040010
重组人il-15蛋白做 NK 扩增与 CTLL-2 测活,读数偏低先查哪三处?五个动作与四类异常
Low Readouts in NK Expansion and CTLL-2 Assays: Where to Check First, Five Moves, Four Anomalies
发布时间 2026-11-16
A troubleshooting guide for human IL-15: reconstitution practice, CTLL-2 proliferation setup, NK expansion conditions and a triage order for low readouts.
View details
  • Immunity/Inflamma
  • IL-15 activity
  • CTLL-2 assay
  • NK cell expansion
  • reconstitution
  • UA040010
重组人il-15蛋白为什么要借别人的 α 链递呈?三段受体与反式递呈的机制
Why IL-15 Borrows Another Alpha Chain: Three Receptor Segments and Trans-Presentation
发布时间 2026-11-16
IL-15 signals through IL-2R beta and gamma but presents via IL-15R alpha on other cells. This article maps trans-presentation and the receptor segments.
View details
  • Immunity/Inflamma
  • IL-15
  • IL-15R alpha
  • trans-presentation
  • CD215
  • CD122
  • NK cell
  • UA040010
Total 3
  • 1
Go to